June 8, 2026
963
14
1
1.56%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
2:08Now PlayingPfizer and Amgen are developing monthly GLP-1 shots with the goal being to make weight loss drugs more convenient and easier to maintain. Injections made by Wegovy and Zepbound are taken weekly. NBC News' Berkeley Lovelace, Jr. explains how users may benefit.
For more context and news coverage of the most important stories of our day, click here
» Subscribe to NBC News
» Subscribe to Here's the Scoop podcast
» NBC News App
» Breaking News Alerts
» Visit NBCNews.Com
» Find NBC News on Facebook
» Follow NBC News on Twitter
» Follow NBC News on Instagram
#Drug #Health #Healthcare
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.